MMP Capital Closes Inaugural Asset-Backed Securitization with Strong Investor Backing

The successful MMP Capital 2025A securitization highlights growing investor appetite for sector-focused ABS deals. Backed by medical aesthetic loans, the transaction attracted strong institutional interest, enabled pricing advantages, and marked MMP Capital's strategic expansion into public capital markets and new asset classes.

Photo Courtesy of MMP Capital

FARMINGDALE, N.Y., Aug. 04, 2025 (GLOBE NEWSWIRE) -- MMP Capital has announced the successful closing of its inaugural Asset Backed Securitization (ABS) transaction. The offering, MMP Capital 2025A, issued $192 million in notes backed primarily by loans secured by medical aesthetic equipment contracts.

Demand from the institutional investment community exceeded all expectations. The notes drew thirty-five orders from twenty-seven unique investors, and at final pricing were nine times oversubscribed. The oversubscription allowed MMP Capital to substantially tighten spreads from launch to close, indicating deep market confidence in the credit quality of ...